AMPH
- Amphastar Pharmaceuticals, Inc.
()
Overview
Company Summary
Amphastar Pharmaceuticals, Inc. is a specialty pharmaceutical company that primarily focuses on the development, manufacturing, and marketing of generic and injectable pharmaceutical products.
The company specializes in delivering complex and critical generic and branded medications to healthcare providers, including hospitals, clinics, and other healthcare facilities. Amphastar's products are primarily designed to address the needs of patients in emergency and acute care settings.
Amphastar's product portfolio consists of a wide range of generic and branded medications across various therapeutic areas, including cardiovascular, central nervous system, and pain management. Some of their well-known products include enoxaparin sodium injection (a generic version of the anti-coagulant Lovenox), naloxone hydrochloride injection (an opioid overdose reversal agent), and adrenaline injection (used to treat severe allergic reactions).
In addition to generic pharmaceuticals, Amphastar also develops and manufactures proprietary injectable products. These include both branded products originating from their own research and development efforts, as well as products they have acquired from other companies through collaborations and partnerships.
Amphastar Pharmaceuticals operates manufacturing facilities in the United States, allowing them to control their production processes and ensure the quality and availability of their products. They maintain a robust supply chain and distribution network to efficiently deliver their pharmaceutical products to customers across various markets.
Overall, Amphastar Pharmaceuticals plays a vital role in providing affordable and accessible healthcare solutions by developing and manufacturing a diverse range of generic and injectable medications that help healthcare professionals treat patients in critical and emergency situations.